|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US7456207||TEVA PHARMS||Vaginal pharmaceutical compositions and methods for preparing them|| |
(11 months from now)
Vandazole is owned by Teva Pharms.
Vandazole contains Metronidazole.
Vandazole has a total of 1 drug patent out of which 0 drug patents have expired.
Vandazole was authorised for market use on 20 May, 2005.
Vandazole is available in gel;vaginal dosage forms.
The generics of Vandazole are possible to be released after 22 September, 2024.
Market Authorisation Date: 20 May, 2005
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic